40 results on '"Locati, Laura Deborah"'
Search Results
2. Carbon ion radiotherapy in gynaecological oncology: where we are and where we are headed
3. Impressive and Prolonged Response with Lenvatinib in a Highly Pretreated Patient with Metastatic Clear Cell Renal Cancer
4. The impact of electronic versus paper-based data capture on data collection logistics and on missing scores in thyroid cancer patients
5. Head and Neck Cancers
6. An eHealth App (CAPABLE) Providing Symptom Monitoring, Well-Being Interventions, and Educational Material for Patients With Melanoma Treated With Immune Checkpoint Inhibitors: Protocol for an Exploratory Intervention Trial
7. Radiation Therapy for Gestational Trophoblastic Neoplasia: Forward-Looking Lessons Learnt
8. Corrigendum: Optimizing the use of lenvatinib in combination with pembrolizumab in patients with advanced endometrial carcinoma
9. Use of lenvatinib in the treatment of radioiodine-refractory differentiated thyroid cancer: a multidisciplinary perspective for daily practice
10. An eHealth App (CAPABLE) Providing Symptom Monitoring, Well-Being Interventions, and Educational Material for Patients With Melanoma Treated With Immune Checkpoint Inhibitors: Protocol for an Exploratory Intervention Trial (Preprint)
11. The observational clinical registry (cohort design) of the European Reference Network on Rare Adult Solid Cancers: The protocol for the rare head and neck cancers
12. Efficacy and activity of treatments after progression from palbociclib plus endocrine therapy in patients with HR+/HER2– metastatic breast cancer: a prospective, monocentric study
13. Ovarian Cancer Radiosensitivity: What Have We Understood So Far?
14. The Interplay between Age and Viral Status in EBV-Related Nasopharyngeal and HPV-Related Oropharyngeal Carcinoma Patients
15. Thrombotic Events during Lenvatinib Treatment: A Single Institution Experience
16. Comparing BamHI-W and CE-marked assays to detect circulating Epstein-Barr Virus (EBV) DNA of nasopharyngeal cancer patients in a non-endemic area
17. Electroporation in Head-and-Neck Cancer: An Innovative Approach with Immunotherapy and Nanotechnology Combination
18. Optimizing the use of lenvatinib in combination with pembrolizumab in patients with advanced endometrial carcinoma
19. How can we address the challenge of distant metastases in HNSCC prognosis?
20. Immunotherapy followed by cetuximab in locally advanced/metastatic (LA/M) cutaneous squamous cell carcinomas (cSCC): The I-TACKLE trial.
21. Complete Response to Nivolumab in Recurrent/Metastatic HPV-Positive Head and Neck Squamous Cell Carcinoma Patient After Progressive Multifocal Leukoencephalopathy: A Case Report
22. An Old but Still Unanswered Question in Recurrent or Metastatic Salivary Duct Carcinoma
23. Prognostic role of pre-treatment magnetic resonance imaging (MRI)-based radiomic analysis in effectively cured head and neck squamous cell carcinoma (HNSCC) patients
24. Radiomics-based prediction of response to multikinase inhibitors in radioiodine-refractory differentiated thyroid cancer patients.
25. Monitoring patients with head and neck cancer for flu-like symptoms during the COVID-19 pandemic
26. Multidisciplinary Management of Radiation-Induced Salivary Gland Carcinomas in the Modern Radiotherapy Era
27. Local therapies for liver metastases of rare head and neck cancers: A monoinstitutional case series
28. Management of loco-regionally advanced squamous laryngeal cancer in elderly patients
29. Prognostic role of pre-treatment magnetic resonance imaging (MRI) radiomic analysis in patients with squamous cell carcinoma of the head and neck (SCCHN).
30. BRAF V600E-mutated anaplastic thyroid carcinoma (ATC) and treatment with BRAF-inhibitors: Real-world data from a single-institution, still far from the cure.
31. Locally advanced epithelial sinonasal tumors: The impact of multimodal approach
32. Retrospective analysis of baseline clinical factors associated to CDDP-nephrotoxicity in locally advanced head and neck cancer (LAHNC) patients.
33. Hyperprogressive disease (HPD) in head and neck squamous cell carcinoma (HNSCC) patients treated with immune checkpoint inhibitors (ICI).
34. Clinical prognostic factors in patients with recurrent or metastatic carcinoma of the head and neck treated with immune checkpoints therapies.
35. Genomics in non-adenoid cystic group of salivary gland cancers: one or more druggable entities?
36. The dilemma of metastatic medullary thyroid carcinoma: when to start systemic treatment
37. In Reply to Fakhry et al
38. Failure of Further Validation for Survival Nomograms in Oropharyngeal Cancer: Issues and Challenges
39. Circulating miR-375 as a novel prognostic marker for metastatic medullary thyroid cancer patients
40. Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.